100 related articles for article (PubMed ID: 3138098)
1. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
[TBL] [Abstract][Full Text] [Related]
2. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
Talaulicar M; Willms B
Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
[TBL] [Abstract][Full Text] [Related]
5. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
6. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
7. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
Hoogma RP; Schumicki D
Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
9. Diabetics treated with continuous subcutaneous insulin infusion pumps.
Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
[TBL] [Abstract][Full Text] [Related]
10. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
[TBL] [Abstract][Full Text] [Related]
11. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
12. Low-dose intravenous insulin infusion versus subcutaneous insulin injection: a controlled comparative study of diabetic ketoacidosis.
Drop SL; Duval-Arnould JM; Gober AE; Hersh JH; McEnery PT; Knowles HC
Pediatrics; 1977 May; 59(5):733-8. PubMed ID: 404621
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic ketoacidosis: results with two different patterns of insulin administration (author's transl)].
Igea J; Martul P; Loridán L; Luzuriaga C
An Esp Pediatr; 1979; 12(8-9):617-22. PubMed ID: 115349
[TBL] [Abstract][Full Text] [Related]
14. No sign of amyloidosis in pump-treated diabetics.
Regal H; Koivisto VA; Maury CP; Irsigler K
Diabetes Res; 1988 Aug; 8(4):195-9. PubMed ID: 3069282
[TBL] [Abstract][Full Text] [Related]
15. Transient severe insulin resistance in diabetic ketoacidosis (a report of four episodes).
Naghmi R; Kaboor M
Horm Metab Res; 1988 Sep; 20(9):584-6. PubMed ID: 3143656
[TBL] [Abstract][Full Text] [Related]
16. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
18. Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective comparison with "conventional" insulin therapy.
Heber D; Molitch ME; Sperling MA
Arch Intern Med; 1977 Oct; 137(10):1377-80. PubMed ID: 411434
[TBL] [Abstract][Full Text] [Related]
19. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump.
Cohen AW; Liston RM; Mennuti MT; Gabbe SG
J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835
[TBL] [Abstract][Full Text] [Related]
20. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections].
Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B
Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
